This article is more than 5 years old. Information may no longer be current.
Primary Acquired Melanosis and Melanoma of the Conjuctiva
Click Here to Manage Email Alerts
Sponsorship Statement: This continuing medical education activity is sponsored by 
Title: Primary Acquired Melanosis and Melanoma of the Conjuctiva
Learning Objectives:
At the conclusion of this activity participants should be able to:
- Describe the clinical features that help distinguish primary acquired melanosis (PAM) of the conjunctiva from other common pigmented conjunctival lesions.
- Compare the potential for the development of conjunctival malignant melanoma in cases of PAM without atypia versus PAM with atypia.
Faculty:
Carol L. Shields, MD
Oncology Service, Wills Eye Institute
Philadelphia, PA
Jerry A. Shields, MD
Oncology Service, Wills Eye Institute
Philadelphia, PA
Peer Reviewer:
William Lloyd, MD
Continuing Medical Education Information:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this educational activity for a maximum of .50 AMA PRA Category 1 Credit tm. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of release, January 20, 2011 to January 19, 2012.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, read the article, complete the CME Post-test, and complete and submit the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the Post-test questions correctly. Upon receipt of the completed materials, if a satisfactory score on the Post-test is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)tm certificate that will be e-mailed to the participant.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Faculty members report the following relationship(s):
Carol L. Shields, MD
No relevant financial relationships to disclose
Jerry A. Shields, MD
No relevant financial relationships to disclose
Peer reviewer reports the following relationship(s):
William Lloyd, MD
No relevant financial relationships to disclose
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Compliance.
Overview: This activity will describe the clinical features that help distinguish primary acquired melanosis (PAM) of the conjunctiva from other common pigmented conjunctival lesions and compare the potential for the development of conjunctival malignant melanoma in cases of PAM without atypia versus PAM with atypia.
Target Audience: This program is designed for ophthalmologists, resident ophthalmologists, and professionals in the field of ophthalmology.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education®, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright© 2011 Vindico Medical Education®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education®. Neither Vindico Medical Education® nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.